Scientific Programme

TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES
Bled, Slovenia, May 28-30, 2017

Agenda (preliminary)
Sunday, 28 May

13.00-19.00 REGISTRATION – Welcome desk (Foyer)
13.00-19.00 EXHIBITION SET UP (Foyer)
13.00-16.00 ICADTS Executive Board meeting (Libertas room)
14.00-22.00 PRE-CONFERENCE VISITS AND WELCOME RECEPTION (at 19.00, Bled Castle)

 

Monday, 29 May

 08.00-19.00 REGISTRATION – Welcome desk (Foyer)
 08.00-18.00 EXHIBITION (Foyer)
 09.00-09.30 WELCOME (Jupiter room)

Introduction: Majda Zorec Karlovšek, President, Association FORTOX

Welcome messages:

Janez Fajfar, Mayor, Municipality of Bled

Kathryn Stewart, President, International Council on Alcohol, Drugs and Traffic Safety

Prof. Santo Davide Ferrara, President, International Academy of Legal Medicine

Vesna Marinko, Slovenian Traffic Safety Agency

Vesna Kerstin Petrič, Ministry for Health, Slovenia

Robert Vehovar, Republic of Slovenia, Ministry of the Interior, Police, General Police Directorate

Robert Štaba, Vicepresident, FEVR (European Federation of Road Traffic Victims | Fédération Européenne des Victimes de la Route), and President of Safe Journey Institute (Zavod Varna pot)

David Razboršek, Director, VOZIM Institute (Zavod Vozim), Leader of the project “I still drive – but I cannot walk”  (Še vedno vozim-vendar ne hodim)

 09.30-10.40 SESSION 1 – TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES

Chair:  Kathryn Stewart, Majda Zorec Karlovšek

 

Taking action in impaired driving worldwide:  Where we have been, where we are going, and the role of ICADTS

Kathryn Stewart

ICADTS, Prevention Research Center, USA

A Paradigm Shift to a Safe System; Lessons from the Netherlands

Wendy Weijermars

SWOV, Netherlands

 

Improving Road Safety in the Western Balkan (“WB6”) countries – Connectivity Agenda 

Liljana Çela             
South East Europe Transport Observatory (SEETO), Republic of Serbia

 

Effective measures to reduce alcohol – related harm: Alcohol policy in Slovenia.

Vesna Kerstin Petrič, Nataša Blažko,

Ministry for Health, Slovenia

10.40-11.00 Break
11.00-12.30 SESSION 1 – TAKING ACTION TO DECREASE ROAD FATALITIES AND INJURIES

Chair: Evelyn Vingilis

 

Tech, Policy and Research Innovations that Launched the Interlock Age

Paul Marques

PIRE, USA

 

Drink and driving – why we so often fail to learn from best practice and experience
Matej Košir and Sanela Talić

Institute for Research and Development “Utrip”, Slovenia

 

Alcohol and driving:  Numbers, trends, attitudes, and new technologies

Majda Zorec Karlovsek

Association FORTOX, Ljubljana, Slovenia

 

Alcohol interlocks and drink driving rehabilitation in the European Union

Sjoerd Houwing

SWOV, The Hague, Netherlands

12.30-13.30 Lunch
13.30-15.00 How to start interlock programmes?

Chair: Sjoerd Houwing, Paul Marques

WORKSHOP – based on »Best practice and guidelines for EU Member States

15.00-15.15 Break
15.15-16.15
 SESSION 2ALCOHOL, DRUGS AND DRIVING –  EPIDEMIOLOGICAL RESEARCH

Chair: Gordon Smith

 

Survey of alcohol and drug use among drivers in the Arctic county of Finnmark (Norway)
Ragnhild Elen Gjulem Jamt, Hallvard Gjerde, Stig Tore Bogstrand
Department of Forensic Sciences, Oslo University Hospital, Oslo, Norway
Psychoactive drugs prescription in DUIA population: An emerging public health and traffic safety concern

Elettra Carini, Carmela Centola, Manuel Papi, Adriano Tagliabracci, Raffaele Giorgetti

Section of Legal Medicine, Università Politecnica delle Marche, Ancona, Italy

Prevalence of drug and polydrug abuse in drunk drivers. Possible implications in the driving license regranting system
Snenghi R1, Pelletti G1, Frigo AC2, Nalesso A1, Favretto D1, Montisci M1, Ferrara SD1
1Legal Medicine and Toxicology, University-Hospital of Padova, Italy;

2Biostatistics, Epidemiology and Public Health Unit, University of Padova, Italy

Forensic Toxicology Unit- Experimental Medicine Department University of Campania “L. Vanvitelli”, Italy

 

Incidence of alcohol and drugs use among drivers injured in road accidents in Campania (Italy) during 2009-2016 years.
Anna Carfora, Paola Cassandro, Anna Cucciardi, Luisa Russello, Raffaella Petrella, Renata Borriello
Forensic Toxicology Unit- Experimental Medicine Department University of Campania “L. Vanvitelli«, Italy

 

Incidence of alcohol and drug use among pedestrians and cyclists fatally injured in road accidents in Slovenia

Ticijana Prijon1, Tomaž Čakš1, Branko Ermenc2

1Health Insurance Institute of Slovenia

2Institute of Forensic  medicine, Medical Faculty, University of Ljubljana Slovenia

 

 

16.15-16.30 Break
16.30-18.00
SESSION 3:  DETECTION OF PSYCHOACTIVE DRUGS

Chair: Jeremy Davey , Kerry Armstrong

Australian roadside drug testing: Moving to a next generational response

Jeremy Davey and  Kerry Armstrong

Centre for Accident Research and Road Safety- Queensland University of Technology, Australia

 

Can the use of Dräger DrugTest 5000 correctly identify drug drivers? Evaluation in a naturalistic setting in Norway

Hallvard Gjerde1, Håvard Furuhaugen1, Grethe Brennhovd Clausen2

1Department of Forensic Sciences, Oslo University Hospital, Norway;

2Norwegian Mobile Police Service, Stavern, Norway

 

Evaluation of some abuse drugs in Patients of an Emergency Hospital

R.A.Adeldayem; R.A.Mandour

Toxicology Unit, Emergency Hospital, Mansoura University, Egypt

 

Technique of receiving antibodies to synthetic cannabinoids «spices» and some antidepressants for development of diagnostic test system

Fazliddin Jalilov1, Lola Pulatova2, Shohista Tashmukhamedov3

1Tashkent Pharmaceutical Institute, Tashkent ,Uzbekistan

2Higher military customs institute, Tashkent, Uzbekistan

3National University of Uzbekistan, Tashkent, Uzbekistan

 

Application of the Thermodesorption surface – ionization spectroscopy method in Amitriptyline analysis
Fazliddin Jalilov1, Mansur Tojiev1, Lola Pulatova2, Feruza Jalilova1
1Tashkent Pharmaceutical Institute, Tashkent,Uzbekistan

2Higher military customs institute, Tashkent, Uzbekistan

 

 

Break 5 min

 

 

SESSION 4: TRAFFIC SAFETY: EDUCATION

Chair: Mary Sheehan

 

Risky Driving Videos on YouTube:  Should We Be Concerned about this Social Medium?

Evelyn Vingilis1, Larissa Vingilis-Jaremko2, Zümrüt Yıldırım-Yenier1, Christine Wickens3, Jane Seeley1, Judy Fleiter4, Daniel H. Grushka1

1Department of Family Medicine, University of Western Ontario, London, Canada, N6A 5C1.

2Department of Psychology, York University, 4700 Keele St., Toronto, Canada M3J 1P3

3Social and Epidemiological Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Canada M5S 2S1

4Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia

 

 

Street Racing Videos and their Popularity – A YouTube Content Analysis
Jane Seeley1, Christine Wickens3, Larissa Vingilis-Jaremko2, Judy Fleiter4, Zümrüt Yildirim-Yenier1, Daniel Grushka1, Evelyn Vingilis1
1Department of Family Medicine, University of Western Ontario, London, Canada, N6A 5C1.

2Department of Psychology, York University, 4700 Keele St., Toronto, Canada M3J 1P3

3Social and Epidemiological Research, Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Canada M5S 2S1

4Centre for Accident Research and Road Safety-Queensland, Queensland University of Technology, Kelvin Grove, Queensland 4059, Australia

 

19.00-22.00 GALA DINNER

 

Tuesday, 30 May

 08.00-15.00 REGISTRATION – Welcome desk (Foyer)
 08.00-15.00 EXHIBITION (Foyer)
8.30-10.40
SESSION 5 – NON-ALCOHOL DRUGS AND DRIVING

Chair:Jan Ramaekers

Drugs and driving: Trends and challenges

Richard Compton,

National Highway Traffic Safety Administration, USA

 

SESSION 6 –  MEDICINAL DRUGS: RECREATIONAL, THERAPEUTIC AND LONG-TERM THERAPEUTIC USE

Chair:Jan Ramaekers

Introduction and background of a Dutch collaboration to assess long term effects of medicinal drugs (classified ICADTS class III) on driver performance

Joris C Verster1,2,3, Aurora J.A.E. van de Loo1,2, Nick N.J.J.M. van der Sluiszen4, Annemiek Vermeeren4, Karel A. Brookhuis5, Janet Veldstra5, Joke H. van Dijken5, Johannes G. Ramaekers4

 

1 Division Pharmacology, Utrecht University, Utrecht, The Netherlands;

2 Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands;

3 Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia;

4 Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands;

5 Faculty of Behavioural and Social sciences, Division Psychology, University of Groningen, The Netherlands

 

Long-term effects of antidepressant and benzodiazepine usage on actual driving and neurocognitive performance

Nick N.J.J.M. van der Sluiszen1, Annemiek Vermeeren1, Joris C. Verster2, Aurora J.A.E. van de Loo2, Karel A. Brookhuis3, Janet Veldstra3 , Joke H. van Dijken3 and Johannes G. Ramaekers1

 

1 Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands;

2 Faculty of Pharmaceutical Sciences, Division Pharmacology, University Utrecht, The Netherlands

3 Faculty of Behavioural and Social sciences, Division Psychology, University of Groningen, The Netherlands

 

Long term effects of antidepressants and benzodiazepines on simulated driving performance.

 

J.H. van Dijken, J.L. Veldstra, K.A. Brookhuis, D. de Waard

University of Groningen, the Netherlands

 

Polypharmacy of ICADTS III drugs and long-term effects on driving
Vinckenbosch F, van der Sluiszen N, Veldstra J, van Dijken J, Verster JC, van de Loo A, Vermeeren A, Brookhuis K, Ramaekers JG
Maastricht University, The Netherlands

 

BREAK 5 min

Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients
Schumacher, M. B., Jongen, S., Knoche, A., Petzke, F., Vuurman, E. F., Vollrath, M., & Ramaekers J.G.

University Maastricht, Federal Highway Research Institute, Universitaetsmedizin Goettingen, Technische Universitaet Braunschweig

 

Therapeutic and recreational use of Codeine, Tramadol, Zolpidem and Ketamine in drivers
Favretto Donata, Visentin Sindi, Bennici Silvia Eugenia, Vogliardi Susanna, Stocchero Giulia, Montisci Massimo, Snenghi Rossella, Ferrara Santo Davide
Legal Medicine and Toxicology, Department of Cardiological, Thoracic and Vascular Sciences, School of Medicine, University Hospital of Padova, Padova, Italy.

 

 

10.40-11.00 Break
11.00-13.10
 

SESSION 7CANNABIS AND DRIVING

 

Cannabis and tolerance: acute drug impairment as a function of cannabis use history.
Ramaekers Jan
Faculty of Psychology and Neuroscience, Division Psychopharmacology, Maastricht University, The Netherlands

Determination of legislative limits for tetrahydrocannabinol in Norway

Vigdis Vindenes

Oslo University Hospital, Section of Drug Abuse Research, Norway

 

The Journey To Legalize Cannabis in Canada
Danielle Y.R. Comeau; Felix J.E. Comeau; Denise Connerty

Alcohol Countermeasure Systems Corp., Toronto, Canada

 

Relationship between medical cannabis, alcohol use and traffic accidents
Dušan Nolimal1,2

1NIJZ – National institute for Public Health,Ljubljana

2ICANNA – International Institute for Cannabinoids, Ljubljana

 

 

Epidemiological studies on risk for crash involvement after cannabis use

Hallvard Gjerde1 and Jørg Mørland2

1Department of Forensic Sciences, Oslo University Hospital, Norway;

2Norwegian Institute of Public Health, Oslo, Norway

 

 

Discussion

 

Closing remarks: Kathryn Stewart

 

13.10-14.10 Lunch

 

Wednesday, 31 May

8.00-22.00 Post-conference visit (Sevnica)